---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-005666"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-27T00:44:10.638651+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health President resigns; appoints new director Ellen Beausang

## Summary
- Dr. Sandra Milligan resigns as President effective Feb 21, 2025, for personal reasons.
- Duties assumed by Jamie Sullivan (Chief of Staff) and Todd Pappas (VP R&D and Lab Ops).
- Ellen Beausang appointed to board; she is President/Chief Commercial Officer of BioReference Health (since June 2022).
- Beausang brings 25+ years experience from Pfizer, Thermo Fisher, Quest Diagnostics; no arrangement or related-party transactions.

## SEC filing metadata
- accession: 0001493152-25-005666
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/0001493152-25-005666-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-005666
- JSON: https://secwatch.observer/filing/0001493152-25-005666.json
- Plain text: https://secwatch.observer/filing/0001493152-25-005666.txt

## Key facts
- Executive change
  Sandra Milligan resigned as President at Aspira Women's Health Inc..
  - Action: resigned
  - Role: President
  source text: Dr. Sandra Milligan, the President of Aspira Women’s Health Inc. (the “Company”) informed the Board of Directors of the Company that she was resigning as President of the Company for personal reasons, effective February 21, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/0001493152-25-005666-index.htm
- Executive change
  Ellen Beausang was appointed as Director at Aspira Women's Health Inc..
  - Action: appointed
  - Role: Director
  source text: the Board of Directors of the Company appointed Ellen Beausang as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/0001493152-25-005666-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.